Skip to content
value.today

Derma Sciences, Inc.

Total raised
$29 M
1 round on record
Latest round
$29 M
Jun 2011
First round on record
Jun 2011
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Derma Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2011$29 MNo. 1$10 to $50 million

Derma Sciences, Inc.: Raise no. 1, Jun 2011

Investors in this round

18 investors had bought by the notice of Jul 5, 2011: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$29 M of $29 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
$1,889,873
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Pennsylvania

People named in the notice

  • Barry J. Wolfenson · Executive Officer
  • Edward J. Quilty · Director, Executive Officer
  • Frederic C. Eigner · Executive Officer
  • John E. Yetter · Executive Officer
  • Robert C. Cole · Executive Officer
  • Brett F. Hewlett · Director
  • Bruce F. Wesson · Director
  • C. Richard Stafford, Esq. · Director
  • James T. O'Brien · Director
  • Richard J. Keim · Director
  • Robert G. Moussa · Director
  • Srini T. Conjeevaram · Director
  • Stephen T. Wills, CPA, MST · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Canaccord Genuity Inc. (CRD 1020) · Boston, MassachusettsSold in MA, NJ, NY
  • Oppenheimer & Co. Inc. (CRD 249) · New York, New YorkSold in MA, NJ, NY

Signed by Edward J. Quilty, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 5, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Derma Sciences, Inc. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Jul 2011).

    SEC Form D (revenue range) · Jul 2011

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jul 2011

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Derma Sciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 18 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Derma Sciences, Inc.
NameRoleNamed in
Barry J. WolfensonExecutive officerJul 2011
Edward J. QuiltyExecutive officerJul 2011
Frederic C. EignerExecutive officerJul 2011
John E. YetterExecutive officerJul 2011
Robert C. ColeExecutive officerJul 2011
Brett F. HewlettDirectorJul 2011
Bruce F. WessonDirectorJul 2011
C. Richard Stafford, Esq.DirectorJul 2011
Edward J. QuiltyDirectorJul 2011
James T. O'BrienDirectorJul 2011
Richard J. KeimDirectorJul 2011
Robert G. MoussaDirectorJul 2011
Srini T. ConjeevaramDirectorJul 2011
Stephen T. Wills, CPA, MSTDirectorJul 2011